Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313404885> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4313404885 endingPage "60.21" @default.
- W4313404885 startingPage "60.21" @default.
- W4313404885 abstract "Abstract The JAK family kinase TYK2 is a key regulator of IL-12 and IL-23 signaling pathways, which have been shown to be involved in the pathogenesis of multiple inflammatory and autoimmune diseases such as psoriasis, lupus and inflammatory bowel diseases (IBD). TYK2 inhibition is an attractive therapeutic strategy for human autoimmune diseases. Here, we report a potent oral TYK2 allosteric inhibitor ARTS-011, with high selectivity and potency through optimized binding to the JH2 regulatory domain of the TYK2 protein. ARTS-011 potently binds to TYK2 JH2 domain in binding assay and inhibits IL-23 and IFNα/β induced reporter activation depending on TYK2 kinase. ARTS-011 also inhibits IFNα triggered pSTAT5 potently in human whole blood assay. In addition, ARTS-011 excellent selectivity against other JAK family kinases and panels of receptors, transporters, ion channels, CYP enzymes and the hERG channel. Furthermore, ARTS-011 was also investigated in multiple animal models including IL12/18-induced serum IFNγ mouse model, IL-23-induced mouse psoriasis model and CD40 antibody-induced mouse inflammatory bowel disease (IBD) model. In vivo pharmacodynamic study indicates that ARTS-011 significantly reverses IL12/18-induced IFNγ production in mouse. ARTS-011 also significantly reduces the ear swelling in a dose-dependent manner in IL-23-induced mouse psoriasis model. Lastly, ARTS-011 was highly efficacious in anti-CD40 antibody induced mouse IBD model. In summary, ARTS-011 is a highly selective, potent and orally available small molecule TYK2 inhibitor with suitable pharmaceutical properties as potential therapeutics in inflammatory disorders." @default.
- W4313404885 created "2023-01-06" @default.
- W4313404885 creator A5004501300 @default.
- W4313404885 creator A5015624914 @default.
- W4313404885 creator A5032201780 @default.
- W4313404885 creator A5035701638 @default.
- W4313404885 creator A5037292392 @default.
- W4313404885 creator A5038165954 @default.
- W4313404885 creator A5038334712 @default.
- W4313404885 creator A5043540785 @default.
- W4313404885 creator A5047916176 @default.
- W4313404885 creator A5078967413 @default.
- W4313404885 creator A5080846501 @default.
- W4313404885 creator A5084697545 @default.
- W4313404885 date "2022-05-01" @default.
- W4313404885 modified "2023-10-17" @default.
- W4313404885 title "Characterization of ARTS-011, a potent and selective TYK2 inhibitor for the treatment of inflammatory disease" @default.
- W4313404885 doi "https://doi.org/10.4049/jimmunol.208.supp.60.21" @default.
- W4313404885 hasPublicationYear "2022" @default.
- W4313404885 type Work @default.
- W4313404885 citedByCount "0" @default.
- W4313404885 crossrefType "journal-article" @default.
- W4313404885 hasAuthorship W4313404885A5004501300 @default.
- W4313404885 hasAuthorship W4313404885A5015624914 @default.
- W4313404885 hasAuthorship W4313404885A5032201780 @default.
- W4313404885 hasAuthorship W4313404885A5035701638 @default.
- W4313404885 hasAuthorship W4313404885A5037292392 @default.
- W4313404885 hasAuthorship W4313404885A5038165954 @default.
- W4313404885 hasAuthorship W4313404885A5038334712 @default.
- W4313404885 hasAuthorship W4313404885A5043540785 @default.
- W4313404885 hasAuthorship W4313404885A5047916176 @default.
- W4313404885 hasAuthorship W4313404885A5078967413 @default.
- W4313404885 hasAuthorship W4313404885A5080846501 @default.
- W4313404885 hasAuthorship W4313404885A5084697545 @default.
- W4313404885 hasConcept C126322002 @default.
- W4313404885 hasConcept C130523297 @default.
- W4313404885 hasConcept C150903083 @default.
- W4313404885 hasConcept C170493617 @default.
- W4313404885 hasConcept C180361614 @default.
- W4313404885 hasConcept C185592680 @default.
- W4313404885 hasConcept C203014093 @default.
- W4313404885 hasConcept C207001950 @default.
- W4313404885 hasConcept C2775960820 @default.
- W4313404885 hasConcept C2778260677 @default.
- W4313404885 hasConcept C2779134260 @default.
- W4313404885 hasConcept C2780564577 @default.
- W4313404885 hasConcept C71924100 @default.
- W4313404885 hasConcept C86803240 @default.
- W4313404885 hasConcept C98274493 @default.
- W4313404885 hasConceptScore W4313404885C126322002 @default.
- W4313404885 hasConceptScore W4313404885C130523297 @default.
- W4313404885 hasConceptScore W4313404885C150903083 @default.
- W4313404885 hasConceptScore W4313404885C170493617 @default.
- W4313404885 hasConceptScore W4313404885C180361614 @default.
- W4313404885 hasConceptScore W4313404885C185592680 @default.
- W4313404885 hasConceptScore W4313404885C203014093 @default.
- W4313404885 hasConceptScore W4313404885C207001950 @default.
- W4313404885 hasConceptScore W4313404885C2775960820 @default.
- W4313404885 hasConceptScore W4313404885C2778260677 @default.
- W4313404885 hasConceptScore W4313404885C2779134260 @default.
- W4313404885 hasConceptScore W4313404885C2780564577 @default.
- W4313404885 hasConceptScore W4313404885C71924100 @default.
- W4313404885 hasConceptScore W4313404885C86803240 @default.
- W4313404885 hasConceptScore W4313404885C98274493 @default.
- W4313404885 hasIssue "1_Supplement" @default.
- W4313404885 hasLocation W43134048851 @default.
- W4313404885 hasOpenAccess W4313404885 @default.
- W4313404885 hasPrimaryLocation W43134048851 @default.
- W4313404885 hasRelatedWork W2399408748 @default.
- W4313404885 hasRelatedWork W2748952813 @default.
- W4313404885 hasRelatedWork W2897411533 @default.
- W4313404885 hasRelatedWork W2899084033 @default.
- W4313404885 hasRelatedWork W3089170113 @default.
- W4313404885 hasRelatedWork W3094223557 @default.
- W4313404885 hasRelatedWork W3209514756 @default.
- W4313404885 hasRelatedWork W4210445733 @default.
- W4313404885 hasRelatedWork W4249186748 @default.
- W4313404885 hasRelatedWork W4254628406 @default.
- W4313404885 hasVolume "208" @default.
- W4313404885 isParatext "false" @default.
- W4313404885 isRetracted "false" @default.
- W4313404885 workType "article" @default.